↓ Skip to main content

Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level

Overview of attention for article published in Radiation Oncology, December 2018
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter
2 X users
facebook
1 Facebook page
googleplus
2 Google+ users

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
43 Mendeley
Title
Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level
Published in
Radiation Oncology, December 2018
DOI 10.1186/s13014-018-1202-z
Pubmed ID
Authors

A. van Linge, R. van Os, N. Hoekstra, B. Heijmen, L. Stienstra, A. Dallenga, J. Wolbers, A. Mendez Romero

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 43 100%

Demographic breakdown

Readers by professional status Count As %
Professor > Associate Professor 6 14%
Other 5 12%
Student > Bachelor 5 12%
Student > Master 3 7%
Professor 2 5%
Other 7 16%
Unknown 15 35%
Readers by discipline Count As %
Medicine and Dentistry 18 42%
Engineering 2 5%
Agricultural and Biological Sciences 1 2%
Nursing and Health Professions 1 2%
Chemistry 1 2%
Other 1 2%
Unknown 19 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 January 2019.
All research outputs
#6,902,475
of 23,120,280 outputs
Outputs from Radiation Oncology
#340
of 2,079 outputs
Outputs of similar age
#140,942
of 437,008 outputs
Outputs of similar age from Radiation Oncology
#10
of 38 outputs
Altmetric has tracked 23,120,280 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 2,079 research outputs from this source. They receive a mean Attention Score of 2.7. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,008 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.